Evidence map›Paper›PMID 39908456›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2025

Developmental immunotoxicity study of tris(chloropropyl) phosphate in Hsd:Sprague Dawley SD rats exposed through dosed feed.

Victor J Johnson, Kristen Ryan, Michael I Luster, Arun Pandiri, Kristen Hobbie, Michelle Cora, Keith R Shockley, Gary R Burleson, Guanhua Xie, Dori R Germolec

Abstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Victor J JohnsonBurleson Research Technologies, Inc, Morrisville, NC 27560, United States.
Kristen RyanDivision of Translational Toxicology, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, United States.
Michael I LusterBurleson Research Technologies, Inc, Morrisville, NC 27560, United States.
Arun PandiriDivision of Translational Toxicology, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, United States.
Kristen HobbieInotiv, Inc, Morrisville, NC 27560, United States.
Michelle CoraDivision of Translational Toxicology, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, United States.
Keith R ShockleyDivision of Intramural Research, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, United States.
Gary R BurlesonBurleson Research Technologies, Inc, Morrisville, NC 27560, United States.
Guanhua XieDLH, LLC, Bethesda, MD 27703, United States.
Dori R GermolecDivision of Translational Toxicology, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, United States.

Funding

Consumer Products and Therapeutics Research ProgramZIAES103379 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI TAYLOR, KYLA · 2022 to 2025
$9.9M
ASRC Federal Data Solutions GS-00F-173CA/75N96022F00055Burleson Research TechnologiesExperimental Pathology Laboratories HHSN75N96023A00001Intramural NIH HHS ZIA ES103379Intramural Research ProgramNIEHS NIH HHS HHSN273201400017CNIEHS NIH HHS HHSN273201400020CNIEHS NIH HHS HHSN273201400022CNIEHS NIH HHS HHSN273201500012CNIEHS NIH HHS HHSN273201500012INIEHS NIH HHS HHSN273201500013CNIEHS NIH HHS HHSN273201500014CNIH HHS ZIA ES103379-01RTI InternationalSocial and Scientific Systems, Inc.
6 · The paper itself

Abstract

Tris(chloropropyl) phosphate (TCPP) is a member of organophosphate flame retardants used commonly as a replacement for polybrominated diphenyl ethers in consumer and commercial products. Flame retardants have been shown to modulate immune function in vivo and in vitro and there is evidence that at least some related compounds such as organophosphate pesticides can cause developmental immunotoxicity. Developmental immunotoxicology studies were conducted by administering 0, 2500, 5000, or 10,000 ppm TCPP in feed to pregnant Hsd:Sprague Dawley SD rats from gestation day 6 through weaning on postnatal day 28. Feed exposure to TCPP was continued in the F1 offspring until terminal euthanasia at ∼16 to 21 weeks of age when assessments for developmental immunotoxicity were conducted. Innate, humoral, and cell-mediated immune function were assessed in the F1 adults. The antibody-forming cells (AFCs) response to sheep red blood cells was reduced in male and female F1 rats in the 10,000 ppm treatment group but coincided with reduced bodyweights. The AFC response was also significantly reduced in male rats exposed to 5000 ppm where only moderate effects on bodyweights occurred. TCPP exposure affected baseline T-cell proliferation without stimulation; however, the relevance of this change for immunotoxicity risk is unknown. TCPP exposure did not affect cytotoxic T-lymphocyte activity. Only minor and inconsistent treatment-related effects on hematology, innate NK cell function, and immune cell population distributions in the spleen were observed. Taken together, these data indicate that TCPP has the potential to impact humoral immune responses following developmental exposure.

Indexed as

Flame RetardantsImmune SystemOrganophosphorus CompoundsPrenatal Exposure Delayed EffectsAnimalsDose-Response Relationship, DrugErythrocytesFemaleImmunity, CellularImmunity, HumoralImmunity, InnateMaleMaternal ExposurePregnancyRatsRats, Sprague-DawleyFlame RetardantsOrganophosphorus Compoundstris(1,3-dichloro-2-propyl)phosphatedevelopmental immunotoxicity testingimmune systemorganophosphate flame retardant (OPFR)tris(chloropropyl) phosphate (TCPP)

Identifiers

PMID39908456
PMCPMC12038234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.